In Life Sciences we enjoy leadership positions across our key products at a global level. professionally managed by separate management teams.
down JubilantLifeSciences AR
Science Ingredients and Drug Discovery Solutions. Each of these segments is professionally managed by its separate management teams headed by respective
down JLL AnnualReport
15-Jun-2017 Science Ingredients and Drug Discovery Solutions. Each of these segments is professionally managed by its separate management teams headed ...
down JLL AnnualReport
Jubilant Life Sciences Limited professionally managed by separate management teams. ... Pharmaceuticals and Life Science Ingredients segments.
down JubilantLifeSciences AR
Jubilant Life Sciences Limited Annual Report 2019-20. Board of direCtors as on July 2020. Priyavrat Bhartia. Director. Arjun Shanker Bhartia. Director.
JubilantLifeSciencesAnnualReport
Jubilant manufactures a range of Life Science chemicals of Acetyl group and holds leadership position in most of them. Acetyls.
jubilant life sciences brochure
Jubilant Life Sciences Limited Annual Report 2014-15. 1. Dr. Ashok Misra Director. Shyamsundar Bang. Executive Director. Shardul S Shroff. Director.
down JLL Annual Report
The management team of Jubilant Life Sciences Limited (Jubilant) – an integrated global pharmaceutical and life sciences company will host a conference call
Q FY Concall Invite
09-Nov-2010 pharma business as Jubilant Life Sciences business and completed the process of ... The Global Management Team of Jubilant is presented.
down down jll csr
Jubilant Life Sciences Limited. 2. Board of Directors. S Sridhar. Director. Dr. Ashok Misra. Director. Sushil Kumar Roongta. Director. Sudha Pillai.
JLL AnnualReport
213477
Partnering for Value Creation
in Life Sciences
Corporate Sustainability Report
2010-11
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
2
1.0Chairmen"s Views04
2.0Impacts, Risks and Opportunities08
3.0The Company 11
4.0Report Sketch and Assurance Statement17
5.0Corporate Governance 20
6.0Commitments to External Initiatives24
7.0Stakeholder Engagement 27
8.0Economic Performance38
9.0Environmental Performance42
10.0Social Performance 61
11.0The Way Forward86
GRI Index88
UNGC Index102
List of Abbreviations103
Application Level Check 105
Feedback Form106
Contents
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
3
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
4
Dear Stakeholders,
This was an eventful year in the history of the Company due to amalgamat ion and demerger of operations with a view of increased focus on Life sciences business. In line with our continued focus on sustainability of our business, we consolidated the pharma business as Jubilant Life Sciences business and completed the process of operating objectives. In continuation with our philosophy of Sustainable Development the focus of the new Company remains in the areas of Economic, Environment and Social performance, the triple bottom line. The Companies which focus on sustainable growth move forward on the growth path tapping the new markets based on clean technology, green reduced consumption etc. High levels of productive activity and widespread poverty can coexist, and can endanger the environment. Hence sustainable development requires that societies meet human needs both by increasing productive potential and by ensuring equitable opportunities for all. The Company makes sure to improve the socio-economic environment they operate in through stakeholder consultation and various social initiatives. Our sustainability initiative is a step towards enabling inclusive growth. 1.0
Chairmen"s
View
Sitting:
S hyam S Bhartia
Chairman and Managing Director
Standing:
Hari
S Bhartia
Co-Chairman and Managing Director
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
5
Partnering for Value Creation
in Life Sciences
Corporate Sustainability Report
2010-11
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
2
1.0Chairmen"s Views04
2.0Impacts, Risks and Opportunities08
3.0The Company 11
4.0Report Sketch and Assurance Statement17
5.0Corporate Governance 20
6.0Commitments to External Initiatives24
7.0Stakeholder Engagement 27
8.0Economic Performance38
9.0Environmental Performance42
10.0Social Performance 61
11.0The Way Forward86
GRI Index88
UNGC Index102
List of Abbreviations103
Application Level Check 105
Feedback Form106
Contents
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
3
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
4
Dear Stakeholders,
This was an eventful year in the history of the Company due to amalgamat ion and demerger of operations with a view of increased focus on Life sciences business. In line with our continued focus on sustainability of our business, we consolidated the pharma business as Jubilant Life Sciences business and completed the process of operating objectives. In continuation with our philosophy of Sustainable Development the focus of the new Company remains in the areas of Economic, Environment and Social performance, the triple bottom line. The Companies which focus on sustainable growth move forward on the growth path tapping the new markets based on clean technology, green reduced consumption etc. High levels of productive activity and widespread poverty can coexist, and can endanger the environment. Hence sustainable development requires that societies meet human needs both by increasing productive potential and by ensuring equitable opportunities for all. The Company makes sure to improve the socio-economic environment they operate in through stakeholder consultation and various social initiatives. Our sustainability initiative is a step towards enabling inclusive growth. 1.0
Chairmen"s
View
Sitting:
S hyam S Bhartia
Chairman and Managing Director
Standing:
Hari
S Bhartia
Co-Chairman and Managing Director
Jubilant Life Sciences Limited
Corporate Sustainability Report
2010-11
5